key: cord-0722277-41xa5wkq
authors: Husser, D.; Hohenstein, S.; Pellissier, V.; Ueberham, L.; Koenig, S.; Hindricks, G.; Meier-Hellmann, A.; Kuhlen, R.; BOLLMANN, A.
title: Potential contributors to increased pulmonary embolism hospitalizations during the Covid-19 pandemic
date: 2021-05-19
journal: nan
DOI: 10.1101/2021.05.18.21257372
sha: ddedfc6ac36a5ced2a5727684fde3511f6029232
doc_id: 722277
cord_uid: 41xa5wkq

Background: After the first Covid-19 infection wave, a constant increase of pulmonary embolism (PE) hospitalizations not linked with active PCR-confirmed Covid-19 has been observed but potential contributors to this observation are unclear. Therefore, we analyzed associations between changes in PE hospitalizations and (1) the incidence of non-Covid-19 pneumonia, (2) the use of computed tomography pulmonary angiography (CTPA), (3) volume depletion and (4) preceding Covid-19 infection numbers in Germany. Methods: Claims data of Helios hospitals in Germany were used and consecutive cases with a hospital admission between May 6 and December 15, 2020 (PE surplus period) were analyzed and compared to corresponding periods covering the same weeks in 2016-2019 (control period). We analyzed the number of PE cases in the target period with multivariable Poisson general linear mixed models (GLMM) including (a) cohorts of 2020 versus 2016-2019, (b) the number of cases with pneumonia, (c) CTPA, and (d) volume depletion and adjusted for age and sex. In order to associate the daily number of PE cases in 2020 with the number of preceding SARS-CoV-2 infections in Germany, we calculated the average number of daily infections (divided by 10,000) occurring 14 up to 90 days with increasing window sizes before PE cases and modelled the data with Poisson regression. Results: There were 2,404 PE hospitalizations between May 6 and December 15, 2020 as opposed to 2,112-2,236 (total 8,717) in the corresponding 2016-2019 control periods. (crude rate ratio [CRR] 1.10, 95% CI 1.05-1.15, P<0.01). Using multivariable Poisson GLMM adjusted for age, sex and volume depletion, PE cases were significantly associated with the number of cases with pneumonia (CRR 1.09, 95 % CI 1.07-1.10, P<0.01), and with CTPA (CRR 1.10, 95 % CI 1.09-1.10, P<0.01). The increase of PE cases in 2020 compared with the control period remained significant (CRR 1.07, 95 % CI 1.02-1.12, P<0.01) when controlling for those factors. In the 2020 cohort, number of preceding average daily Covid-19 infections were associated with increased PE case incidence in all investigated windows, i.e. including preceding infections from 14 to 90 days. The best model (log likelihood -576) was with a window size of 4 days, i.e. average Covid-19 infections 14-17 days before PE hospitalization had a risk of 1.20 (95 % CI 1.12-1.29, P<0.01). Conclusions: There is an increase in PE cases since early May 2020 compared to corresponding periods in 2016-2019. This surplus was significant even when controlling for changes in potential modulators such as demographics, volume depletion, non-Covid-19 pneumonia, CTPA use and preceding Covid-19 infections. Future studies are needed (1) to investigate a potential causal link for increased risk of delayed PE with preceding SARS-CoV-2 infection, and (2) to define optimal screening for SARS-CoV-2 in patients presenting with pneumonia and PE.

Results: There were 2,404 PE hospitalizations between May 6 and December 15, 2020 as opposed to 2,112 -2,236 (total 8,717) in the corresponding 2016 -2019 control periods.

(crude rate ratio [CRR] 1.10, 95% CI 1.05 -1.15, P<0.01). Using multivariable Poisson GLMM adjusted for age, sex and volume depletion, PE cases were significantly associated with the number of cases with pneumonia (CRR 1.09, 95 % CI 1.07−1.10, P<0.01), and with CTPA (CRR 1.10, 95 % CI 1.09−1.10, P<0.01). The increase of PE cases in 2020 compared with the control period remained significant (CRR 1.07, 95 % CI 1.02−1.12, P<0.01) when controlling for those factors. In the 2020 cohort, number of preceding average daily . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 infections were associated with increased PE case incidence in all investigated windows, i.e. including preceding infections from 14 to 90 days. The best model (log likelihood -576) was with a window size of 4 days, i.e. average Covid-19 infections 14 -17 days before PE hospitalization had a risk of P<0.01) .

There is an increase in PE cases since early May 2020 compared to corresponding periods in 2016 -2019. This surplus was significant even when controlling for changes in potential modulators such as demographics, volume depletion, non-Covid-19 pneumonia, CTPA use and preceding Covid-19 infections. Future studies are needed (1) to investigate a potential causal link for increased risk of delayed PE with preceding SARS-CoV-2 infection, and (2) to define optimal screening for SARS-CoV-2 in patients presenting with pneumonia and PE.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 After the first Covid-19 infection wave, we 1 and others 2 have observed a constant increase of pulmonary embolism (PE) hospitalizations not linked with active PCR-confirmed Covid-19. Compared with previous years, we found the 2020 surplus cohort to have less severe disease indicated by less thrombolytic therapy, intensive care, mechanical ventilation and inhospital-mortality rates as well as shorter hospitalizations despite similar comorbidity burden. 1 Potential contributors to this observation are unclear and could include undetected SARS-CoV-2 infection in pneumonia cases, more computed tomography use in suspected Covid-19 pneumonias, volume depletion due to the 2020 heat wave or complications of preceding Covid-19. [3] [4] [5] Therefore, we analyzed associations between changes in PE hospitalizations and (1) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 We analyzed the number of cases in the target period with multivariable Poisson general linear mixed models (GLMM) including (a) cohorts of 2020 versus 2016-2019, (b) the number of cases with pneumonia, (c) CTPA, and (d) volume depletion and adjusted for age and sex.

In order to associate the daily number of PE cases in 2020 with the number of preceding SARS-CoV-2 infections in Germany, 6 we calculated the average number of daily infections (divided by 10,000) occurring 14 up to 90 days with increasing window sizes before PE cases and modelled the data with Poisson regression.

We report CRR or odds ratios (OR, calculated by exponentiation of the regression coefficients) together with 95% confidence intervals (CI) for the comparisons of the different periods and P values for the interactions. For all tests, we apply a two-tailed 5% error criterion for significance. This study was approved by the Ethics Committee at the Medical Faculty, Leipzig University (#490/20-ek). Due to the retrospective study of anonymized data, informed consent was not obtained.

There were 2,404 PE hospitalizations between May 6 and December 15, 2020 as opposed to 2,112 -2,236 (total 8,717) in the corresponding 2016 -2019 control periods. (CRR 1.10, 95% CI 1.05 -1.15, P<0.01). As depicted in Figure 1 In the 2020 cohort, number of preceding average daily Covid-19 infections were associated with increased PE case incidence in all investigated windows, i.e. including preceding infections from 14 to 90 days. The best model (log likelihood -576) was with a window size of 4 days, i.e. average Covid-19 infections 14 -17 days before PE hospitalization had a risk of 1.20 (95 % CI 1.12-1.29, P<0.01).

By analyzing claims data of the German-wide Helios hospital network, we have identified an increase in PE cases since early May 2020 compared to corresponding periods in 2016 -2019. 1,2 This surplus was significant even when controlling for changes in potential modulators such as demographics, volume depletion, non-Covid-19 pneumonia, CTPA use and preceding Covid-19 infections.

Pneumonia and PE are known to coexist 7 which is supported by the observed association between the two diseases. We could demonstrate that the total number of pneumonia cases was reduced in 2020, most likely due to social distancing and other lockdown measures, but at the same time CTPA use in general and in non-Covid-19 pneumonia cases (with even higher diagnostic sensitivity of pneumonia detection) increased. pneumonias could in fact be undetected SARS-CoV-2 infections with higher PE risk. 8 Delayed PE following SARS-CoV-2 infection has also been reported, 3 and PE was the reason . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 for hospital readmissions in 0.6% patients after recovery from Covid-19 in previous studies. 4, 5 This observation is supported by our newly identified association between preceding Covid-19 and PE case numbers although this does not prove causality. Despite the inclusion of those variables into the multivariable prediction model, PE remained higher in 2020, suggesting that other undetected factors are contributing to this observation. For instance, use of glucocorticoids -frequently prescribed in SARS-COV-2 pneumonias -have been shown to associate with a higher PE risk within 30 days after exposure 9 but data on medication is not available in our cohorts. In addition, other factors such as hypercoagulability, platelet function and hypoxia which are associated with both Covid-19 infection and venous thrombosis including PE are also potential confounders but have not been analyzed.

Future studies are needed (1) to investigate a potential causal link for increased risk of delayed PE with preceding SARS-CoV-2 infection, and (2) to define optimal screening for SARS-CoV-2 in patients presenting with pneumonia and PE.

DH was supported by the Volkswagen Foundation Germany through the Lichtenberg professorship program (# 84901).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 

Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic -Emergence of different phenotypes of thrombotic disease?

Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study

Delayed pulmonary embolism after COVID-19 pneumonia: a case report

Assessment of thirty-day readmission rate, timing, causes, and predictors after hospitalization with Covid-19

Puerta de Hierro Hospital Admission Study Group. Hospital readmissions of discharged patients with Covid-19

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

Clinical characteristics of pulmonary embolism with concomitant pneumonia

Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experience

Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021